Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-000658-67Phase 2Completed
Phase 2, open-label, single-arm trial of deferiprone in hemochromatosis (HH), sponsored by Consorzio per Valutazioni Biologiche e Farmacologiche. Primary endpoint: Pharmacokinetic endpoints. Started Aug 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-000658-67.